Skip to main content

GLP-1 medications and cancer

Interest in the use of GLP-1 medications for weight loss is growing rapidly. Learn what they are, what the current evidence says and where research is heading.

A person lifts their shirt and injects GLP-1 medication into their abdomen while standing in a bedroom, a routine that has sparked recent discussions about the possible links between GLP-1 medications and cancer.

GLP-1 medications (GLP-1s) have attracted significant attention in recent years. Originally developed to treat type 2 diabetes, GLP-1s – such as semaglutide, liraglutide and tirzepatide – are increasingly being used for weight loss.

With excess body weight increasing the risk of at least 13 cancers and as more people use these medications to manage overweight and obesity, many are asking what GLP-1s could mean for cancer prevention and for people living with and beyond cancer. For World Cancer Research Fund (WCRF), this is a critical question.

Researchers around the world are actively investigating these questions but the evidence is still emerging. We know that maintaining a healthy weight can help reduce the risk of several cancers. Studies are now exploring whether GLP-1s could also have a role in cancer prevention and survivorship as well as assessing what their long-term impact may be.

Find out what GLP-1s are, why they’re relevant to cancer and what the current evidence says. As research continues to evolve, this information will be updated to reflect the latest evidence.

What are GLP-1s?

Glucagon-like peptide-1 (GLP-1) is a natural hormone released by the gut that helps regulate blood glucose and appetite. GLP-1 medications mimic or enhance the natural GLP-1 hormone, helping you feel fuller for longer and reducing your appetite. They also slow down how quickly food moves through your stomach, which can help you eat less and lose weight.

GLP-1 medications can help people living with overweight and obesity manage their weight. They can also be used to help people with type 2 diabetes control their blood sugar levels. Common examples include semaglutide, tirzepatide and liraglutide. Brand names include Ozempic, Wegovy, Mounjaro and Saxenda.

Semaglutide: GLP-1 receptor agonist

Brand name How it is taken What it may be prescribed for in the UK
Ozempic Injection Type 2 diabetes
Rybelsus Tablet Type 2 diabetes
Wegovy Injection or tablet Weight management for adults who meet specific clinical criteria

Liraglutide: GLP-1 receptor agonist

Brand name How it is taken What it may be prescribed for in the UK
Saxenda Injection Weight management for adults who meet specific clinical criteria
Diavic Injection Type 2 diabetes
Zegluxen Injection Type 2 diabetes

Tirzepatide: Acts on GLP-1 and GIP pathways

Brand name How it is taken What it may be prescribed for in the UK
Mounjaro Injection Type 2 diabetes and weight management for adults who meet specific clinical criteria

Orforglipron: GLP-1 receptor agonist

Brand name How it is taken What it may be prescribed for in the UK
Foundayo Tablet Type 2 diabetes and weight management for adults who meet specific clinical criteria

These medications are prescription-only. Although they are licensed for these uses, they may not always be available on the NHS. Access may vary depending on local services and clinical eligibility.

These medications are prescribed as part of a treatment plan that includes healthy lifestyle changes, such as eating a healthy, balanced diet and being physically active. They are not suitable for everyone, so treatment should always be discussed with a qualified health professional like a GP.

Read more

Weight, obesity and cancer

Discover the link between weight and cancer risk, the science behind it, and ways to reach and maintain a healthy weight.

Check your BMI

BMI calculator

Use our BMI calculator to check your body mass index and see if you’re within the healthy weight range.


Why are people asking about GLP-1s and cancer?

Maintaining a healthy weight is one of the most important ways to help reduce the risk of cancer. We know that too much body fat increases the risk of at least 13 types of cancer, which is why ‘be a healthy weight’ is one of our Cancer Prevention ecommendations.

Because GLP-1 medications can help people lose weight, researchers are exploring whether they could also have an impact on cancer risk. At the same time, scientists are studying their long-term safety and whether they have any direct effects on cancer beyond weight loss.

As interest in these medications continues to grow, so does the amount of research being carried out to better understand their potential role in cancer prevention and for people living with and beyond cancer.

Read more

Our Cancer Prevention Recommendations

Discover our Cancer Prevention Recommendations and the positive changes you can make to your diet, weight and physical activity to help reduce cancer risk.

Read more

Obesity history in cancer patients

Recent research suggests more than half of cancer patients have a history of obesity. Read about the findings and what they could mean for cancer care.


What does the evidence currently say?

Research into GLP-1 medications and cancer is developing rapidly, but there are still important questions to answer. Current evidence shows that these medications can be effective in the management of obesity and type 2 diabetes, and maintaining a healthy weight is linked to a lower risk of several cancers.

Researchers are now investigating whether the health benefits seen with GLP-1s could also influence cancer risk, as well as looking at their potential role for people living with and beyond cancer. Some of the key questions that need to be answered include:

  • How do these medications affect outcomes and treatment in people living with and beyond cancer?
  • What are the potential risks of these medications for people living with and beyond cancer?
  • How do effects differ between medications, people and cancer types?

For more information, see our position statement.

At present, there isn’t enough evidence to draw firm conclusions about the relationship between GLP-1 medications and cancer prevention, treatment or survivorship.

If you’re living with or beyond cancer and are considering GLP-1 medications, speak to your healthcare team who can advise you based on your individual circumstances. As more high-quality studies are completed, our understanding will continue to evolve.

Find out more about our work on GLP-1s and cancer, which is happening across the World Cancer Research Fund network of charities, including the American Institute for Cancer Research (AICR) in the US and the Wereld Kanker Onderzoek Fonds (WKOF) in the Netherlands:

Read more

National Cancer Plan

We welcome England’s National Cancer Plan and its ambition to improve survival and care, while calling for stronger action to put cancer prevention at its heart.

Read more

Obesity, the immune system and cancer

Dr Mike Coleman’s research, supported by the Marilyn Gentry AICR/WCRF Fellowship, explores how obesity affects the immune system’s ability to fight cancer and the impact of weight loss.

Read more

The weight loss medication revolution

AICR spotlights Dr Kristin Altwegg, recipient of the AICR/WCRF Marilyn Gentry Fellowship, and her research exploring GLP-1 medications, exercise and cancer risk.

Read more

Can GLP-1s reduce risk of cancer?

Listen to Five to Thrive Live on Spotify, where Dr Kristin Altwegg discusses GLP-1 medications, weight loss and their potential role in reducing cancer risk.


Looking after your health

Healthy lifestyle habits are important for your overall health, to lower your risk of cancer and for people living with and beyond cancer. Healthy habits may be especially important for people taking GLP-1 medications as they can help support nutrition, muscle strength and long-term health.

1. Eat well and stay hydrated

Eat a healthy, balanced diet with a variety of foods, including:

  • Fibre-rich foods, such as fruit, vegetables, wholegrains (like brown rice), pulses (like beans and chickpeas) and unsalted nuts. These provide important vitamins and minerals and can support gut health.
  • Protein foods, such as beans, lentils, fish, eggs, chicken, yoghurt and tofu. Eating enough protein, particularly alongside doing exercises that strengthen your muscles (see more below), may help you maintain muscle while losing weight.
  • Calcium-rich foods, such as yoghurt, milk, cheese, calcium-fortified dairy alternatives and calcium-set tofu. These can help support bone health.

Drink 6-8 glasses of water a day.

If you don’t have much of an appetite, or side effects make it hard for you to eat, choose smaller meals and snacks throughout the day. Choose foods that give you important nutrients, such as vitamins, minerals (like calcium), fibre and protein.

2. Move more and build strength

Aim for 20-30 minutes of moderate-intensity activity a day, such as brisk walking, or 10-15 minutes of vigorous-intensity activity a day, such as fast cycling, or a mix of both.

Include strength-building activities on at least 2 days a week, such as resistance exercises, carrying shopping, gardening, yoga or Pilates. Doing exercises that strengthen your muscles may help you maintain muscle while losing weight.

If you are not active at the moment, start slowly and build up gradually. Any movement is better than none.

3. Other advice to reduce your cancer risk

Limit alcohol, sugary drinks, red and processed meat, and foods high in fat, salt and sugar (like crisps and chocolate).

Avoid smoking and keep safe in the sun.

For more support

Speak to a qualified health professional such as a doctor, nurse or dietitian if side effects or poor appetite do not improve or make it hard to eat, drink or stay active.

Read more

Living well

Find practical advice on eating well, staying active and managing your weight, with trusted information and support for living well with and beyond cancer.

Read more

Our Cancer and Nutrition Helpline

Get free, personalised nutrition advice from our specialist oncology dietitians, with practical support to help you eat well during and after cancer treatment.